|
Erythromycin Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Genmab1
Indications
- Primary Refractory Ovarian Cancer1
- Platinum Sensitive Ovarian Cancer (PSOC)1
- Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)1
- High Grade Epithelial Ovarian Cancer1
- Platinum-resistant Ovarian Cancer (PROC)1
Phoenix, Arizona1 trial
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
USOR HonorHealth
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.